Bridgeport, CT — In a recent legal ruling, Johnson & Johnson was ordered to pay $15 million in compensatory damages to a plaintiff who claimed its talcum powder caused his mesothelioma. The decision was reached after a month-long trial in the Bridgeport Judicial District Court. Evan Plotkin, 64, who was diagnosed with the disease in 2021, is at the center of this case marking another significant verdict against the pharmaceutical giant.
The jury, addressing the claims against Johnson & Johnson’s baby powder, also found punitive conduct by the company, which will lead to further determinations of punitive damages by the presiding judge. Ben Braly, Plotkin’s attorney from Dean Omar Branham Shirley, expressed his client’s relief and satisfaction that the jury acknowledged the alleged negligence in Johnson & Johnson’s product.
According to Braly, “This verdict is a moment of accountability for a company that, as we demonstrated, knew about the potential harm of their product.” Johnson & Johnson, however, has consistently denied these claims, asserting the safety of its talcum powder being free from asbestos and its non-carcinogenic properties.
Johnson & Johnson’s defense, led by Bill Oxley of Orrick, Herrington & Sutcliffe, has signaled an imminent appeal. Erik Haas, worldwide vice president of litigation for Johnson & Johnson, criticized the trial’s rulings. “Critical facts were excluded during the trial, which might have proved the plaintiff’s type of mesothelioma was not linked to talcum powder,” Haas argued. He further alleged that the litigation was propelled by what he described as unreliable scientific claims financed by plaintiffs’ law firms.
Amid these courtroom battles, Johnson & Johnson is also embroiled in a complicated bankruptcy case involving its subsidiary, Red River Talc. The subsidiary’s Chapter 11 filing, which is not directly associated with current mesothelioma cases, seeks to consolidate claims that its talcum powders led to ovarian cancer and other illnesses. This bankruptcy case has been ordered to proceed in the Southern District of Texas, a decision made by U.S. Bankruptcy Judge Christopher Lopez on October 10.
This legal development comes after three substantial verdicts earlier this year achieved by Plotkin’s law firm against Johnson & Johnson, tallying to millions of dollars in Chicago, Oregon, and South Carolina courts respectively for similar claims. Additionally, in Dallas County, another case settled before reaching a jury decision.
Legal experts suggest that these continuous high-profile suits and the substantial awards granted to plaintiffs may encourage more claims. Moreover, the outcomes could significantly impinge on Johnson & Johnson’s financial health and its public image regarding product safety.
As Johnson & Johnson navigates these series of legal setbacks, industry watchers and legal analysts will be monitoring the implications of these cases on regulations and consumer confidence in talc-based products across the sector.
Meanwhile, potential punitive damages in the Bridgeport case will be determined at a later date, a decision awaited by many to see the full extent of the financial repercussions Johnson & Johnson might face from this verdict. The plaintiffs’ legal teams see these cases as pivotal in holding corporations accountable, while Johnson & Johnson advocates for what it sees as preserving the integrity of scientific findings in judicial processes.